Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TTP054 Phase 2 in Type 2 Diabetes
NCT01665352Phase 2Completed
- Sponsor
- vTv Therapeutics
- Start
- Aug 2012
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ttp054 in type 2 diabetes mellitus (T2DM), sponsored by vTv Therapeutics. Started Aug 2012; status: completed.
02
Drugs
ttp054
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01665352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01665352.